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Summary The protective effect of onion against oxidative stress in streptozotosin-induced
diabetic rats was investigated in comparison with that of quercetin aglycone. We measured
oxidative stress biomarkers involving the susceptibility of the plasma against copper ion-
induced lipid peroxidation, which was estimated by the amounts of thiobarbituric acid-
reactive substances (TBARS) and cholesteryl ester hydroperoxides, and urine TBARS and 8-
hydroxydeoxyguanosine contents. After the 12-week feeding period, plasma glucose levels and
these biomarkers increased in diabetic rats compared to normal rats. In diabetic rats fed a
6.0% onion diet (quercetin equivalent: 0.023%), quercetin metabolites accumulated in the
plasma at concentrations of approximately 35 µM. Onion intake decreased plasma glucose levels
and lowered the oxidative stress biomarkers. On the other hand, quercetin metabolites in the
plasma of rats fed a diet with 0.023% quercetin aglycone were found at lower concentrations
(14.2 µM) than the rats fed the onion diet. Furthermore, oxidative stress biomarkers were
higher in the quercetin diet group compared to the onion diet group. These results strongly
suggest that onion intake suppresses diabetes-induced oxidative stress more effectively than
the intake of the same amount of quercetin aglycone alone.
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Introduction
Food plants contain a variety of polyphenolic compounds
including flavonoids. In recent years, flavonoids have attracted
much attention for their physiological functions. Dietary
flavonoids are expected to have a protective effect against
atherosclerosis which can lead to coronary heart disease by
acting, at least in part, as an antioxidant on the oxidation of
low-density lipoproteins and other oxidative events [1–3].
Epidemiological studies have shown an inverse relationship
between the intake of flavonoids and the risk of coronary
heart disease [4–6]. Quercetin, a typical flavonol-type
flavonoid, is ubiquitously present in vegetables, fruits and
tea, mostly as its glycoside form. It composes the largest part
of flavonoid intake from daily foods and is known to possess
high antioxidant activity. Thus, dietary quercetin is thought
to be important in the light of the prevention of oxidative
stress-related diseases.
Absorption and metabolic conversion of quercetin have
been investigated by a large number of researchers and it is
now clarified that the main pathway for quercetin glycosides
is conversion to conjugate metabolites by deglycosylation and
following glucuronide/sulfate conjugation [7–9]. Although
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quercetin glycosides are subject to deglycosidation by entero-
bacteria for absorption in large intestine, the presence of a
glucoside-hydrolyzing activity in small intestinal cells [10]
and their glucose transport system also participate in the
glucoside absorption [11, 12]. Therefore, the small intestine
acts as an effective absorption site for glucose-bound glyco-
sides.
Onion (Allium cepa L.) is known as a quercetin-rich
vegetable [13] and has a high content of quercetin glucosides
(mainly quercetin 4'-glucoside and quercetin 3,4'-diglucoside)
[14, 15]. Previous studies have reported the absorption of
quercetin from dietary onion and its consequences [16–26].
We have previously shown that co-ingestion of lipids or
emulsifiers enhanced the accumulation of quercetin metabo-
lites in rat blood plasma after the short-term intake of onion
from the diet [16], as well as the absorption efficiency of
orally administered quercetin in rats [17]. Onion intake was
found to improve the diabetic status, including protection of
DNA against oxidative damage, lowering of peroxidized
lipids in the circulation and urine, and hypoglycemic and
hypocholesterolemic effects [20,  22,  23]. Quercetin has
already been shown to reduce the oxidative stress in strepto-
zotocin (STZ)-induced diabetic rats [24, 25]. However, the
significance of onion intake as a dietary source of quercetin
for preventing diabetes-related oxidative stress is still unclear.
This study aimed to clarify the in vivo antioxidative effect
of onion intake by assessing oxidative stress biomarkers in
STZ-induced diabetic rats and comparing them with those of




One variety of yellow-type onion (Allium cepa L.),
‘Doctor quercy’, was cultivated in Hokkaido and was
supplied by Takii Seed Co. (Kyoto, Japan). This onion
sample was freeze-dried and pulverized in a sample mill
(WB-1 Wonder Blender, Osaka Chemical Co., Osaka,
Japan). Cornstarch, sucrose, casein, cellulose powder, AIN-
76 mineral mix and AIN-76 vitamin mix supplemented with
choline hydrogen tartrate were purchased from Oriental
Yeast Co. (Tokyo, Japan) to prepare semipurified diets. STZ,
quercetin dehydrate, soybean oil and glutathione were
purchased from Wako Pure Chemical Ind. (Osaka, Japan).
Sulfatase type H-5 (from Helix pomatia), 2-thiobarbituric
acid, glutathione (GSH) reductase, NADPH, and tert-
butylhydroperoxide were purchased from Sigma Chemical
Co. (St. Louis, MO). Quercetin 3-glucoside (Q3G) and
isorhamnetin were obtained from Extrasynthese (Geney,
France). Quercetin 4'-α-D-glucoside (Q4'G) and quercetin
3,4'-α-D-diglucoside (Q3,4'G) were supplied by Dr. T.
Tsushida of the National Food Research Institute (Tsukuba,
Japan). Cholesteryl ester hydroperoxides (CEOOH) for a
standard compound were prepared by the method described
by Arai et al. [27]. All other chemicals were of analytical or
HPLC grade.
Measurement of quercetin glucosides in onion
Quercetin glucosides were extracted by suspending
200 mg of onion powder in 4 ml of 70% methanol for
24 h in darkness at room temperature with occasional
vigorous shaking. After centrifuging at 3000 × g for 5 min,
the extraction was repeated. The supernatants were com-
bined and 70% methanol was added to a volume of 10 ml.
The extract was passed through a 0.20-µm filter and
analyzed by HPLC under the following conditions: column,
TSK gel ODS-80Ts (5 µm, 4.6 × 150 mm; Tosoh, Tokyo,
Japan); mobile phase, water-methanol-acetic acid (30:68:2,
v/v/v); flow rate, 0.9 ml/min; column temperature, 35°C. The
quercetin glucosides eluted from the column were monitored
at 360 nm. They were identified from their retention times
against those of respective standard compounds, and their
concentrations were calculated using standard curves for
each quercetin glucoside.
Animals and diets
Nine-week-old male Wistar rats weighing 190–200 g
were purchased from Japan SLC (Hamamatsu, Japan) and
fed a commercial diet (MF, Oriental Yeast Co., Tokyo, Japan)
for 5 days before being used in the experiment. The animals
were kept in an environmentally controlled animal facility
operated on a 12 h dark/light cycle at 23 ± 1°C and 55%
humidity. Diabetes was induced by a single intraperitoneal
injection of STZ (25 mg/kg of body weight in 0.9% NaCl).
Three days after this injection, fasting blood glucose levels
were monitored using a commercial kit (glucose CII-test
Wako; Wako Pure Chemical Ind., Osaka, Japan). Rats with
blood glucose levels above 230 mg/dl were divided into
three diabetic groups (diabetic control (DC), diabetic-onion
(DO), and diabetic-quercetin (DQ)) of 6 rats each. One
group of 6 untreated rats was included in this study as
normal control (NC) group. For the following 12 weeks,
each group of rats was fed the semipurified basal diet (NC
and DC groups), onion diet containing 6.0% onion powder
(DO group) or quercetin diet containing 0.026% quercetin
dihydrate (DQ group) as shown in Table 1 ad libitum. Both
onion diet and quercetin diet contained equivalent amounts
of quercetin (0.023% quercetin aglycone). Body weights of
the rats were monitored at weekly intervals, and plasma
quercetin metabolite concentrations were determined at 3-
week intervals. At the end of the experimental period, 24 h
urine samples were collected. After an overnight fast, the
blood was collected from the hearts under ether anesthesia
and plasma was immediately separated by centrifugation at
1000 × g  for 15 min at 4°C. The liver, kidney and heartProtection of Oxidative Stress by Onion
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were taken and weighed after perfused with a PBS (10 mM
phosphate-buffered saline, pH 7.2) containing 0.16 mg/ml
heparin to remove any red blood cells and clots. Liver and
kidney samples were immediately frozen in liquid nitrogen.
Plasma, urine and organ samples were stored at −80°C until
analysis. These animal experiments were performed under the
guidelines for animal experiments according to Notification
No. 6 of the Japanese government.
Determination of quercetin metabolites in rat plasma
The quercetin metabolites in rat plasma were quantitatively
determined by HPLC according to the method previously
described [17]. Plasma (50 µl) was mixed with 50 µl of a
sulfatase type H-5 (25 units of sulfatase and 500 units of β-
glucuronidase) solution in a 0.1 mM sodium acetate buffer
at pH 5.0. The mixture was incubated at 37°C for 50 min.
The released compounds were extracted by adding 900 µl of
methanol-acetic acid (100:5, v/v) to the reaction mixture,
vortexing for 30 s, sonicating for 30 s, again vortexing for
30 s, and finally centrifuging for 5 min at 4°C and 5000 × g.
The supernatant was diluted with water (1:1, v/v), and 20 µl
was injected into a CAPCELL PAK C18 MG HPLC column
(5 µm, 4.6 × 150 mm; Shiseido, Tokyo, Japan). Isocratic
elution was carried out with a mobile phase composed of
water-methanol-acetic acid (53:45:2, v/v/v) and 50 mM
lithium acetate at a flow rate of 0.9 ml/min. The eluate was
monitored with a coulometric electrochemical detector
(Coulochem II with a model 5010 analytical cell; ESA,
Chelmsford, MA). The potential of electrodes 1 and 2 was
+100 mV and +800 mV, respectively, vs the Pd reference.
Quercetin and isorhamnetin were determined by an external
standard method. The detection limits for quercetin and
isorhamnetin were 5 nM and 10 nM, respectively, with a
linear detector response up to 20 µM.
Determination of cholesterol and triacylglycerol in plasma
Total cholesterol, high-density lipoprotein cholesterol, free
cholesterol and triacylglycerol in plasma were determined
with respective enzymatic assay kits (Wako Pure Chemical
Ind., Japan). The content of cholesteryl ester was calculated
by subtracting free cholesterol from total cholesterol.
Measurement of thiobarbituric acid-reactive substances
(TBARS) and CEOOH
The plasma TBARS concentration was determined by
the fluorometric assay of Yagi [28]. The urea TBARS
concentration was measured by the method of Kosugi et al.
[29]. The liver TBARS levels were determined by the method
of Uchiyama and Mihara [30] using the homogenate, which
was prepared by homogenizing the liver with 9 volumes of
20 mM phosphate buffer (pH 7.4). For the measurement of
CEOOH in plasma, 100 µl of plasma which was 4 times
diluted with PBS (pH 7.4) was added to 3 ml of methanol
containing 2.5 mM butylhydroxytoluene (BHT) and 3 ml of
hexane. After vigorous mixing, the hexane layer was
obtained and evaporated in vacuo. The residue was mixed
with the solution of methanol/chloroform (95:5, v/v) and
subjected to HPLC analysis for the determination of
CEOOH [31]. HPLC was performed with a column of TSK-
gel Octyl-80Ts (5 µm, 4.6 × 150 mm, Tosoh) and a mobile
phase of 97% methanol at a flow rate of 1.0 ml/min.
CEOOH was detected at 235 nm absorption.
Copper ion-induced lipid peroxidation of plasma and
measurement of lipid peroxidation level
CuSO4 was added to plasma which was 4 times diluted
with PBS (pH 7.4) at the final concentration of 0.5 mM and
incubated at 37°C with continuous shaking. The peroxidation
level after 24 h incubation was monitored with TBARS
assay and CEOOH concentrations as described above.
Measurement of plasma antioxidative activity
The antioxidative activity was measured with an ELISA
kit “Potential Anti Oxidant” for measuring a copper ion-
reducing activity (Nikken SEIL Co. LTD., Japan Institute of
the Control of Aging, Fukuroi, Japan).
Determination of 8-hydroxydeoxyguanosine (8-OHdG) and
creatinine in urine
8-OHdG and creatinine in urine were determined with an
ELISA kit “New 8-OHdG Check” (Nikken SEIL Co. LTD.,
Japan Institute of the Control of Aging) and a creatinine
assay kit (Wako Pure Chemical Ind., Japan), respectively.
Measurement of liver glutathione peroxidase (GPx) activity
Livers (0.5–1.0 g) were exactly weighed, added with 9
volumes of PBS (10 mM, pH 7.2), and homogenized with
Polytron homogenizer (KINEMATICA, AG, Co., Littau-
Table 1. Composition of the diets (%)
Ingredient Basal diet Onion diet Quercetin diet
Cornstarch 48.2 45.3 48.1
Sucrose 9.9 9.3 9.9
Casein 24.7 23.2 24.7
Cellulose powder 7.9 7.4 7.9
Mineral mix1 3.4 3.2 3.4
Vitamin mix2 1.0 0.9 1.0
Soybean oil 4.9 4.7 4.9
Onion powder 0.0 6.0 0.0
Quercetin dihydrate 0.0 0.0 0.026
1AIN-76 mineral mix (Oriental Yeast Co., Japan), 2AIN-76 vitamin
mix supplemented with choline hydrogen tartrate (Oriental Yeast
Co.)K. Azuma et al.
J. Clin. Biochem. Nutr.
134
Lucerne, Switzerland). After centrifugation for 5 min at 4°C
and 10,000 × g, the resulting supernatants were diluted 100
times and used as liver samples for measuring GPx activity.
All procedures were performed in an ice bath and the liver
samples were stored at −80°C until assay. GPx activity was
determined according to the method described by Flohe and
Gunzler [32]. For the assay, 0.1 ml of Tris-HCl buffer (1 M,
pH 8.0) added with 5 mM EDTA, 0.5 ml of distilled water,
0.1 ml of GSH (20 mM), 0.1 ml of GSH reductase (10 U/
ml), 0.1 ml of NADPH (2 mM), and 0.1 ml of liver sample
were mixed in the cuvette and prewarmed for 2 min at 37°C.
Then 0.1 ml of tert-butylhydroperoxide (7 mM) was added
and the consumption of NADPH at 37°C was monitored at
3 4 0n m  f o r  5m i n .
Data analysis
Each reported value is presented as the mean ± SD. A
statistical analysis was conducted by Dunnett’s post hoc
multiple-comparison test to identify significantly different
means, using StatView for Windows Ver. 5.0 (SAS Institute,
Cary, NC). The level of significance was set at p<0.05.
Results
Content of quercetin glucosides in onion
The content of quercetin glucosides in the freeze-dried
onion used here were determined by HPLC analysis
(Table 2). Q3,4'G and Q4'G were present as major quercetin
glucosides and Q3G as a minor glucoside. The total content
of quercetin glucosides in this onion was 3.84 ± 0.31 mg of
quercetin aglycone equivalent per gram of dry weight.
Effect of onion on growth, food intake and organ weight
Table 3 shows the average food intake during the feeding
period, the body weight gain and the organ weights after the
feeding period. The average food intake was significantly
higher in the diabetic rat groups (DC, DO and DQ), com-
pared to normal rat group (NC). Average quercetin intakes in
DO and DQ groups were 6.91 ± 0.53 and 6.69 ± 0.44 mg as
quercetin aglycone equivalent per kilogram of initial body
weight, respectively, and the difference of the average
quercetin intakes between the two groups was insignificant.
Despite more food intake, the body weight of diabetic
groups (DC, DO and DQ) was reduced after the trial, in
contrast to the NC group. Of organ weights, the liver and
kidney weights were significantly higher in the diabetic rat
groups (DC, DO and DQ) compared to the NC group,
although no significant differences were observed among
the three diabetic rat groups.
Accumulation of quercetin metabolites in plasma
In either NC or DC group, no prominent peak corre-
sponding to quercetin aglycone appeared in the chromato-
gram of the extract from rat plasma treated with sulfatase H-
5, which possesses both sulfatase activity and glucuronidase
activity. On the other hand, two distinct peaks corresponding
to quercetin aglycone and isorhamnetin (3'-methoxyquercetin),
as identified in our previous papers [16, 17], emerged in the
chromatograms of the DO and DQ groups. However, no
peak appeared in the chromatograms without sulfatase H-5
treatment. These results indicate that conjugated quercetin and
conjugated isorhamnetin accumulated in the plasma, which
liberated their aglycone by hydrolysis with sulfatase H-5.
Fig. 1 shows the plasma concentrations of conjugated
quercetin and conjugated isorhamnetin of the DO and DQ
groups during the feeding period. The total quercetin metabo-
lite concentrations, which were calculated as the sum of con-
Table 2. Quercetin glucoside content of onion ‘Doctor quercy’
Compound
Content (mg of quercetin aglycone 
equivalent/g dry weight)
Quercetin 3,4'-diglucoside 1.49 ± 0.12
Quercetin 3-glucoside 0.07 ± 0.01
Quercetin 4'-glucoside 2.28 ± 0.18
Total 3.84 ± 0.31
Values are means ± SD (n = 3).
Table 3. Average food intake, body weight gain and organ weights in rats after the feeding period
Group1 NC DC DO DQ
Average food intake (g/day) 16.8 ± 1.1a 29.4 ± 2.1b 30.0 ± 2.3b 29.1 ± 1.9b
Body weight gain (g) 72 ± 9a −39 ± 16b −22 ± 19b −44 ± 9b
Organ weight (% of body weight)
Heart 0.28 ± 0.02 0.35 ± 0.06 0.31 ± 0.02 0.32 ± 0.03
Liver 2.53 ± 0.17a 3.39 ± 0.30b 3.26 ± 0.38b 3.32 ± 0.34b
Kidney 0.67 ± 0.06a 1.27 ± 0.13b 1.18 ± 0.09b 1.21 ± 0.17b
1NC, normal rats fed basal diet; DC, diabetic rats fed basal diet; DO, diabetic rats fed onion diet; DQ, diabetic
rats fed quercetin diet. Rats were kept on the diets ad libitum for 12 weeks. Onion diet and quercetin diet
contained equal amounts of quercetin (0.023% quercetin aglycone). Values are means ± SD (n = 6). Values with
different superscripts are significantly different (p<0.05).Protection of Oxidative Stress by Onion
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jugated quercetin and conjugated isorhamnetin concentrations,
were significantly higher in the DO group compared to the
DQ group.
Effect of onion intake and quercetin intake on glucose,
cholesterol and triacylglycerol levels in blood plasma
Table 4 shows the concentrations of glucose, cholesterol
and triacylglycerol in blood plasma after the feeding period.
Plasma glucose levels in the DC group were remarkably
higher than that of the NC group. Increased glucose levels in
diabetic rats were lowered by onion intake (DO group) but
not by quercetin intake (DQ group). Plasma triacylglycerol
levels were lower in the DO and DQ groups compared to the
DC group. On the other hand, no significant effects of both
onion intake and quercetin intake on cholesterol levels were
observed.
Effect of onion intake and quercetin intake on TBARS and
CEOOH levels in plasma and liver
The DC group showed higher plasma TBARS and
CEOOH levels than the NC group (Table 5). These lipid
peroxidation biomarkers tended to be lower in the DO and
DQ groups than in the DC group, although no significant
difference was observed among the three groups. Liver
TBARS levels were not significantly different between the
DC and NC groups. No significant differences were observed
among the DC, DO and DQ groups.
Susceptibility of plasma to lipid peroxidation
Fig. 2 shows TBARS and CEOOH levels in rat plasma
after incubation with copper ion. Both levels significantly
increased in the order of NC group<DO group and DQ
group<DC group after 24 h incubation. This result indicates
Fig. 1. Concentrations of quercetin metabolites in the plasma of diabetic rats fed onion diet or quercetin diet. Onion diet and quercetin
diet containing equal amounts of quercetin (0.023% quercetin aglycone) were fed diabetic rats ad libitum for 12 weeks. Values
are means ± SD (n = 6).
*Significantly different from the rat group fed onion diet (p<0.05).
Table 4. Concentrations of glucose, cholesterol and triacylglycerol in rat plasma after the feeding
period.
Group1 NC DC DO DQ
Glucose (mg/dl) 126 ± 18a 515 ± 47b 437 ± 32c 509 ± 41b
Total cholesterol 68 ± 98 3 ± 10 77 ± 15 85 ± 14
HDL-cholesterol 57 ± 66 1 ± 86 6 ± 12 71 ± 13
Free cholesterol 19 ± 32 4 ± 42 2 ± 42 5 ± 5
Esterified cholesterol 49 ± 65 9 ± 65 5 ± 11 60 ± 9
Triacylglycerol 73 ± 12a 116 ± 17b 69 ± 14a 84 ± 15a
1NC, normal rats fed basal diet; DC, diabetic rats fed basal diet; DO, diabetic rats fed onion diet;
DQ, diabetic rats fed quercetin diet. Rats were kept on the diets ad libitum for 12 weeks. Onion diet
and quercetin diet contained equal amounts of quercetin (0.023% quercetin aglycone). Values are
means ± SD (n = 6). Values with different superscripts are significantly different (p<0.05).K. Azuma et al.
J. Clin. Biochem. Nutr.
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that the susceptibility of plasma to copper ion-induced lipid
peroxidation of diabetic rats was higher than that of normal
rats and that the intake of onion or quercetin suppressed
diabetes-induced enhancement of the susceptibility to plasma
lipid peroxidation.
Effect of onion intake or quercetin intake on TBARS, 8-
OHdG and creatinine levels in urine
TBARS and 8-OHdG in urine were markedly increased
in DC group compared to NC group (Fig. 3). Although no
significant differences were observed in TBARS and 8-
OHdG among the three diabetic rat groups, the DO group
tended to exhibit lower values than the DC and DQ groups.
Creatinine level did not differ significantly among the four
groups.
Effect of onion intake and quercetin intake on hepatic GPx
activity
Fig. 4 shows hepatic GPx activity after the feeding period.
Diabetic rats (DC group) tended to exhibit higher activity
compared to normal rats (NC group). No significant
difference was observed in the activity among the DC, DO
and DQ groups, indicating that the neither onion intake nor
quercetin intake affected hepatic GPx activity under diabetic
conditions.
Discussion
The composition of quercetin glucosides in the onion of
this study agreed with those reported previously [14, 15].
From the total content of 3.84 ± 0.31 mg quercetin aglycone
equivalent per gram of dry weight and the water content of
10.1% of this onion, the total quercetin glucoside content
was calculated as 38.0 mg of quercetin aglycone equivalent
per 100 g fresh weight. Since most yellow onion varieties
cultivated in Japan and USA contain less than 30 mg of
quercetin aglycone equivalent per 100 g fresh weight [14,
15], the onion variety used in this study is one of the richest
in quercetin glucosides among the yellow onion varieties.
Conjugated quercetin and conjugated isorhamnetin accu-
mulated as quercetin metabolites in the blood plasma of
rats fed the onion diet or the quercetin diet. The plasma
concentrations of conjugated isorhamnetin were higher than
those of conjugated quercetin in both rat groups. Isorhamnetin,
that is 3'-methoxyquercetin, has been reported to have in
vitro antioxidative activity, although the activity is lower than
quercetin [33]. Therefore, the conjugates of isorhamnetin are
expected to act as antioxidants in vivo.
Approximately twice higher concentrations of quercetin
Table 5. TBARS and CEOOH levels in plasma and liver of rats
after the feeding period.
Group1 NC DC DO DQ
Plasma
TBARS (µM) 6.4 ± 1.1a 10.0 ± 1.9b 8.1 ± 1.5ab 8.4 ± 1.6ab




128 ± 11 136 ± 16 130 ± 12 132 ± 10
1NC, normal rats fed basal diet; DC, diabetic rats fed basal diet;
DO, diabetic rats fed onion diet; DQ, diabetic rats fed quercetin
diet. Rats were kept on the diets ad libitum for 12 weeks. Onion
diet and quercetin diet contained equal amounts of quercetin
(0.023% quercetin aglycone). Values are means ± SD (n = 6). Values
with different superscripts are significantly different (p<0.05).
Fig. 2. Copper ion-induced lipid peroxidation in rat plasma after the feeding period. Rats were kept on basal diet, onion diet, or
quercetin diet ad libitum for 12 weeks. Onion diet and quercetin diet contained equal amounts of quercetin (0.023% quercetin
aglycone). NC, normal rats fed basal diet; DC, diabetic rats fed basal diet; DO, diabetic rats fed onion diet; DQ, diabetic rats fed
quercetin diet. Values are means ± SD (n = 6). Values with different superscripts are significantly different (p<0.05).Protection of Oxidative Stress by Onion
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metabolites were accumulated in the plasma of the onion
diet group compared to the quercetin diet group, despite of
the intake of the same amount of quercetin as its aglycone
equivalent (Fig. 1). It is therefore likely that quercetin gluco-
sides in onion (mainly Q4'G and Q3,4'G) are absorbed more
efficiently than quercetin aglycone. Superior absorption of
quercetin glucoside to its aglycone may be explained by
quercetin glucoside-specific cellular uptake through an
intestinal sodium-dependent glucose transporter or effective
hydrolysis of quercetin glucoside by β-glucosidase activity
of intestinal epithelial cells [11,  12]. Alternatively, some
coexisting components in onion may enhance its intestinal
absorption.
It is known that STZ-induced diabetic rats exhibit
increases in serum glucose concentrations and the weight
ratio of kidney to body weight and the decrease of the body
weight gain [34, 35]. The present study also showed the
same effects in STZ administration to the rats. Neither onion
diet nor quercetin diet affected the weight ratio of kidney to
body weight and the body weight gain in the diabetic rats.
However, plasma glucose levels were significantly decreased
by onion diet, as reported previously by Babu et al. [22]. On
the other hand, quercetin diet showed no significant effect
on plasma glucose level. This result indicates that onion
Fig. 3. TBARS, 8-OHdG and creatinine levels in rat urine after the feeding period. Rats were kept on basal diet, onion diet, or
quercetin diet ad libitum for 12 weeks. Onion diet and quercetin diet contained equal amounts of quercetin (0.023% quercetin
aglycone). NC, normal rats fed basal diet; DC, diabetic rats fed basal diet; DO, diabetic rats fed onion diet; DQ, diabetic rats fed
quercetin diet. Values are means ± SD (n = 6). Values with different superscripts are significantly different (p<0.05).
Fig. 4. Hepatic glutathione peroxidase activity after the feeding
period. Rats were kept on basal diet, onion diet, or
quercetin diet ad libitum for 12 weeks. Onion diet and
quercetin diet contained equal amounts of quercetin
(0.023% quercetin aglycone). NC, normal rats fed basal
diet; DC, diabetic rats fed basal diet; DO, diabetic rats
fed onion diet; DQ, diabetic rats fed quercetin diet.
Values are means ± SD (n = 6).K. Azuma et al.
J. Clin. Biochem. Nutr.
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intake, but not quercetin intake, is effective for suppressing
the development of diabetes.
Both onion diet and quercetin diet lowered the plasma
triacylglycerol level, which is known to increase in STZ-
induced diabetic rats [22]. It has been reported that lipid
peroxidation products including TBARS in plasma [22, 25]
and tissues [36] were increased in STZ-induced diabetes and
that plasma TBARS was lowered by onion diet or quercetin
diets [22, 25]. In the present study, we found that both onion
diet and quercetin diet showed a tendency to lower both
plasma TBARS and CEOOH.
Susceptibility of the plasma to lipid peroxidation, as
indicated by the increase of TBARS and CEOOH after
the addition of copper ion, was significantly attenuated by
both onion diet and quercetin diet, indicating that both diets
enhance the antioxidative activity of blood plasma. Sanders
et al. [24] showed that the oral administration of quercetin in
diabetic rats brought about significant decrease in hepatic
GPx activity, which is known to be increased in diabetic
animals [37, 38]. In our study, hepatic GPx activity tended to
be lowered by both onion intake and quercetin intake. Three
oxidative stress biomarkers in urine, that is, 8-OHdG,
TBARS and creatinine, tended to be reduced by onion diet
but not by quercetin diet, indicating that the attenuating
effect of onion intake against oxidative stress in diabetes is
superior to that of quercetin intake.
There are some previous papers on the hypoglycemic
effects [25, 39] and insulin secretion-enhancing effects [40,
41] of quercetin. The intraperitoneal injection of quercetin
(10 and 15 mg/kg body weight) for 10 days [39] and oral
administration of quercetin (50 and 80 mg/kg body weight)
for 45 days [25] were shown to decrease the plasma glucose
level of STZ-induced diabetic rats. From these findings, the
hypoglycemic effect of onion intake observed in the present
study may be attributed to quercetin in onion. The result that
quercetin intake had no significant hypoglycemic effect in
this experiment is likely to be caused by lower absorption
efficiency and bioavailability of quercetin aglycone compared
to quercetin glucosides in onion.
The superiority of onion intake to quercetin diet in lowering
oxidative stress biomarkers in urine also may be at least
in part caused by higher absorption efficiency and bio-
availability of quercetin glucosides compared to its aglycone.
Onion contains sulfur-containing compounds such as dialkyl
disulfides and their oxidized thiols, which can trap electrons
from other systems [42]. Onion oil containing these compounds
has been reported to have an antioxidative effect against the
oxidative damage caused by nicotine in experimental animals
[43, 44]. Thus, these constituents also may contribute to the
protective effects of onion against oxidative stress in STZ-
induced diabetic rats.
In conclusion, quercetin glucosides from onion accumu-
lated in the plasma as their conjugated metabolites at higher
concentration compared to the ingestion of equal amounts of
quercetin aglycone, and dietary onion lowered plasma glucose
and oxidative stress biomarkers either more effectively or
equally to quercetin diet. Overall, the protective effects of
quercetin-rich onion intake seem to be higher or at least
equal to the intake of quercetin aglycone in diabetes-induced
oxidative stress. Further studies on the antioxidative effect of
quercetin glucosides and other components including sulfur-
containing compounds in diabetes are required to assess the
significance of dietary onion in the attenuation of diabetes-
related oxidative stress.
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